In contrast, the subcutaneous adipose tissues of obese individuals and patients with type 2 diabetes display reduced PPARG activity [39], and PPARG activation in adipocytes was reported to be sufficient to reduce insulin resistance [40], hallmark of hypertrophic obesity. This evidence concerns the gene PPARG and Insulin resistance.